Skip to main content
915 TLDR
Health
1 read

El Paso Confirms Tuberculosis Cases at ICE Detention Center on Fort Bliss

KVIA••Valeria Medina
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

The City of El Paso has confirmed the presence of tuberculosis at Camp East Montana, an ICE detention facility located on Fort Bliss. While the exact number of cases has not been disclosed, federal regulations mandate that ICE report confirmed or suspected TB cases. The El Paso Department of Public Health is involved in reviewing these cases and entering information into the National Electronic Diseases Surveillance System (NEDSS). ICE and its medical contractors are responsible for the treatment of affected individuals while in custody, and the city will coordinate follow-up care if any individuals are released into the community to ensure public health safety.

Key Details: • ICE must report confirmed or suspected tuberculosis cases. • El Paso Department of Public Health reviews TB cases and enters data into NEDSS. • Treatment for TB is managed by ICE and its medical providers. • Follow-up care will be coordinated for any released individuals with TB.

ice fort-bliss public-health tuberculosis disease-surveillance

People & Organizations

Fort BlissEl Paso Department of Public HealthICECamp East Montana

Related Articles

KVIA•Apr 14

Key Updates: Military Setbacks, Health Concerns, and Sports Controversies

Recent reports highlight significant issues affecting various sectors. The USS Gerald R. Ford, America's largest aircraft carrier, faces setbacks after a fire incident during its extended deployment, raising concerns about military readiness. Health experts warn that ultraprocessed foods are leading to alarming increases in health issues, with some individuals developing marbled flesh, a sign of serious conditions. In the sports world, the Enhanced Games are set to allow legal doping, attracting athletes with promises of substantial financial rewards. These developments underscore pressing health and ethical challenges in society.

Health
1 min read
KVIA•Apr 14

Estudio revela beneficios de medicamentos GLP-1 más allá de la pérdida de peso

Un nuevo estudio ha encontrado que los medicamentos GLP-1, como Wegovy y Zepbound, ofrecen beneficios significativos para la salud que no dependen de la pérdida de peso. Aunque entre el 10% y el 15% de los usuarios son considerados 'no respondedores' en términos de reducción de peso, estos fármacos pueden mejorar la salud cardiovascular y hepática. Wegovy ha sido aprobado para tratar la esteatohepatitis asociada a disfunción metabólica, que afecta al 6% de los adultos en EE. UU. Los investigadores sugieren que las aseguradoras deben reconsiderar sus criterios de cobertura, ya que los beneficios metabólicos podrían ser más amplios de lo que se pensaba anteriormente.

Health
1 min read
KVIA•Apr 14

Estudio revela que alimentos ultraprocesados afectan la salud muscular en El Paso

Un nuevo estudio destaca los efectos negativos de los alimentos ultraprocesados en la salud muscular, revelando que más del 50% de las calorías consumidas por adultos en EE. UU. provienen de estos productos. Investigadores de la Universidad de California encontraron que el consumo elevado de estos alimentos se asocia con un aumento de grasa intramuscular, lo que puede contribuir a problemas de salud como la osteoartritis de rodilla. Las resonancias magnéticas de 615 participantes mostraron que aquellos con dietas ricas en ultraprocesados presentaban una calidad muscular comprometida. Este hallazgo es preocupante, dado que la debilidad muscular puede aumentar el riesgo de complicaciones en la salud, especialmente en personas con obesidad. Se recomienda adoptar una dieta más saludable y realizar ejercicios de bajo impacto para mejorar la calidad muscular.

Health
1 min read
El Paso Matters•Apr 14

El Paso Mother Advocates for Faster FDA Approval of Rare Disease Treatments

Angelina Olivera, a resident of El Paso, expresses her frustration with the FDA's delays in approving treatments for rare diseases, particularly Duchenne muscular dystrophy, which affects her son Ryu. As Dr. Vinay Prasad departs from the FDA, Olivera highlights the urgent need for accelerated drug approvals, especially after the agency halted the only approved gene therapy for Duchenne following tragic patient deaths. Families of children with rare diseases are suffering as they wait for essential treatments that could prolong their lives. Olivera's advocacy at a Senate hearing has garnered bipartisan support, but she urges new FDA leadership to prioritize these urgent cases to prevent further decline in patients' health.

Health
1 min read